Bionime

BIONIME was founded in April 2003, specializing in biotechnology and medical testing services. The first product series was the Self-Monitoring of Blood Glucose (SMBG) system. BIONIME integrates top expertise from the fields of medicine, chemistry, electronics, and precision machinery to commercialize patented technology with a unique test strip structure. The company’s products include blood glucose monitoring devices and blood glucose test chips for the measurement and monitoring of blood glucose levels.